UK markets open in 2 hours 56 minutes

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.60-0.24 (-2.71%)
At close: 04:00PM EDT
8.72 +0.12 (+1.39%)
After hours: 05:45PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
59,606
59,606
3,686
0
0
Cost of revenue
4,987
4,987
754
0
0
Gross profit
54,619
54,619
2,932
0
0
Operating expenses
Research development
110,575
110,575
182,435
145,558
115,308
Selling general and administrative
185,145
185,145
122,124
60,971
21,337
Total operating expenses
295,720
295,720
304,559
206,529
136,645
Operating income or loss
-241,101
-241,101
-301,627
-206,529
-136,645
Interest expense
29,712
29,712
15,652
0
0
Total other income/expenses net
11,786
11,786
5,821
173
967
Income before tax
-259,027
-259,027
-311,458
-206,356
-135,678
Income tax expense
3,113
3,113
0
0
-
Income from continuing operations
-262,140
-262,140
-311,458
-206,356
-135,678
Net income
-262,140
-262,140
-311,458
-206,356
-135,678
Net income available to common shareholders
-262,140
-262,140
-311,458
-206,356
-135,678
Basic EPS
-4.33
-
-5.66
-4.18
-3.80
Diluted EPS
-4.33
-
-5.66
-4.18
-3.80
Basic average shares
61,357
-
55,032
49,406
35,668
Diluted average shares
61,858
-
55,032
49,406
35,668